
|Articles|February 1, 2018
- Pharmaceutical Executive-02-01-2018
- Volume 38
- Issue 2
Pharmaceutical Executive, February 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Pharma's Image Fix: Lessons from the Fieldabout 8 years ago
The Innovation Distinction: Biopharma's Reputational Passabout 8 years ago
Valeant’s Northern Faceabout 8 years ago
More New Drugs and Generics Reshape Pharma Marketsabout 8 years ago
Leadership in All the Right Placesabout 8 years ago
Industry Engine CheckNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
2
The Turning Point for Oral Biologics: Q&A With Morten Graugaard
3
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
4
FDA’s Shift Signals a New Era for Data-Driven Drug Development
5




